Oral Antibiotic Treatment of Helicobacter Pylori Reduces Intestinal Colonization Rates With Oxalobacter Formigenes
NCT01300039 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2011-02-21
Summary
The investigators are finding out if giving antibiotics for Helicobacter pylori will eliminate colonization of the colon by Oxalobacter formigenes.
Conditions
- Nephrolithiasis
Sponsors & Collaborators
-
VA New York Harbor Healthcare System
lead FED
Principal Investigators
-
David S Goldfarb, MD · New York Harbor VA Medical Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-01-31
- Primary Completion
- 2008-06-30
- Completion
- 2008-06-30
More Related Trials
-
Effects of H.Pylori Eradication on Microbiome
NCT03231332 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Auto Fecal Microbial Transplant Post Helicobacter Pylori Antibiotic Therapy
NCT05329636 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Impact of Ceftriaxone and/or Fluoroquinolone (FQ) Treatment on the Gut Microbiota of Hospitalized Patients.
NCT02031588 ·Status: TERMINATED
-
Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal Infections
NCT00752219 ·Status: COMPLETED ·Phase: PHASE2
-
Antimicrobial Susceptibility for Helicobacter Pylori Eradication
NCT01486082 ·Status: UNKNOWN
-
Developing Microbials to Fight Extended-spectrum Beta-lactamase (ESBL)-Producing Escherichia Coli
NCT04764500 ·Status: ACTIVE_NOT_RECRUITING
-
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
NCT01381562 ·Status: TERMINATED ·Phase: PHASE2
-
One Sequencing Find All for Helicobacter Pylori Infection
NCT03837990 ·Status: UNKNOWN
-
Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
NCT01345929 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Beta-lactams on the Microbiota and Relative Fecal Abundance of Mulltidrug Resistant Bacteria
NCT03338738 ·Status: COMPLETED ·Phase: NA
-
Fecal Microbiota Transplantation (FMT) to Decolonize Antibiotic - Resistant Bacteria (ARB) - New Protocol
NCT06156956 ·Status: RECRUITING ·Phase: NA
-
Identification of Gut Microbiome Biomarkers Associated to Acquisition of Enterobacteriae Highly Resistant to Third Generation Cephalosporines Following Ceftriaxone Treatment.
NCT03569917 ·Status: TERMINATED ·Phase: NA
-
Emergence of Bacterial Resistance to Antibiotics in the Digestive Microbiota of Patients Treated With Anticancer Drugs
NCT07093593 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae
NCT02420366 ·Status: COMPLETED
-
Colonization With Extended-Spectrum Beta-Lactamase (ESBL)-Producing Organisms
NCT01324726 ·Status: COMPLETED
-
Microbial Epidemiology and Chlorhexidine Suscebtibily of Oropharyngeal and Intestinal Colonization
NCT02839980 ·Status: COMPLETED
-
Antibiotic Resistant Community-Acquired E. Coli
NCT00298103 ·Status: COMPLETED
-
Bacterial Metallophores in the Diagnosis of Acute Pyelonephritis
NCT05674032 ·Status: UNKNOWN
-
Biofilms on Short-term Indwelling Ureteral Stents
NCT02845726 ·Status: COMPLETED
-
Impact of Prolonged Antibiotic Therapy on Commensal Microbial Community Gene Expression.
NCT05169255 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention and Decolonization of Multidrug-resistant Bacteria With Probiotics
NCT03967301 ·Status: UNKNOWN ·Phase: NA
-
Feasibility Studies to Inform Novel Proposals to Avert Community-Based Antimicrobial Resistance Spread
NCT02666274 ·Status: UNKNOWN
-
Ampicillin-sulbactam Resistant E.Coli at UPMC
NCT00619580 ·Status: WITHDRAWN
-
Antimicrobial Combination Therapy for Treatment of Enterococcus Faecalis Bacteremia
NCT06833593 ·Status: RECRUITING
-
Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects
NCT00081744 ·Status: COMPLETED ·Phase: PHASE3